In 1972, John Wojtowicz attempted to rob a Brooklyn bank to pay for his lover’s sex-change operation. The story was the basis for the film Dog Day Afternoon. The Dog captures John, who shares his story for the first time in his own unique, offensive, hilarious and heartbreaking way.
You May Also Like
APEX: The Secret Race Across America is a documentary film that takes viewers on a fast-paced ride through the illegal, underground world of U.S. transcontinental racing. How fast can you drive cross-country?
Two brothers return to a small mountain town in search of their long lost parents only to discover that the place has a monstrous taste for tourists.
Rodney Copperbottom is a young robot inventor who dreams of making the world a better place, until the evil Ratchet takes over Big Weld Industries. Now, Rodney’s dreams – and those of his friends – are in danger of becoming obsolete.
Cherry Grove (Fire Island, NY) is the first openly LGBTQ community in the United States. One of the most accepting resort communities in the world, it is a place where everyone can discover who they really and enjoy being a free spirit.
Billy Hayes is caught attempting to smuggle drugs out of Turkey. The Turkish courts decide to make an example of him, sentencing him to more than 30 years in prison. Hayes has two opportunities for release: the appeals made by his lawyer, his family, and the American government, or the “Midnight Express”.
Dr Derek Muller takes us on an epic adventure, a world-spanning investigation of vitamin science and history, asking how do we decide whether to take vitamin supplements, or not?
Filmmaker Jamie Redford embarks on a surprising journey across the U.S. to meet entrepreneurs, community activists and ordinary citizens who are pioneering the use of clean energy technology, often in the most unlikely places, in the process creating jobs, turning profits and making Americans’ lives healthier.
In April of 1945, Germany stands at the brink of defeat with the Russian Army closing in from the east and the Allied Expeditionary Force attacking from the west. In Berlin, capital of the Third Reich, Adolf Hitler proclaims that Germany will still achieve victory and orders his generals and advisers to fight to the last man. When the end finally does come, and Hitler lies dead by his own hand, what is left of his military must find a way to end the killing that is the Battle of Berlin, and lay down their arms in surrender.
Years after the onset of the Clone Wars, the noble Jedi Knights lead a massive clone army into a galaxy-wide battle against the Separatists. When the sinister Sith unveil a thousand-year-old plot to rule the galaxy, the Republic crumbles and from its ashes rises the evil Galactic Empire. Jedi hero Anakin Skywalker is seduced by the dark side of the Force to become the Emperor’s new apprentice – Darth Vader. The Jedi are decimated, as Obi-Wan Kenobi and Jedi Master Yoda are forced into hiding. The only hope for the galaxy are Anakin’s own offspring – the twin children born in secrecy who will grow up to become heroes.
Joaquim Pinto has been living with HIV and VHC for almost twenty years. “What now? Remind Me” is the notebook of a year of clinical studies with toxic, mind altering drugs as yet unapproved. An open and eclectic reflection on time and memory, on epidemics and globalization, on survival beyond all expectations, on dissent and absolute love. In a to-and-fro between present and past memories, the film is also a tribute to friends departed and those who remain.
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski’s gene-targeted cancer medicines he discovered in the 1970’s called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.
